ArticlePharmacoepidemiology and drug safety2024

Regulatory Impact of Selected U.S. FDA Postmarketing Safety Registries Conducted for Drugs Used to Treat Inflammatory or Autoimmune Conditions.

Zakaridja Guiriansoro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.